| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |